ISBT 128 for Cellular Products, Tissues, Derivatives and Beyond
Program Code: 094570
Wednesday, January 14, 2009
2:00 PM to 3:30 PM (ET)

MODERATOR
Veronica Lewis, MS, MT(ASCP)SBB, Rush University

SPEAKERS
Scott Brubaker, CTBS, American Association of Tissue Banks
D. Michael Strong, PhD, StrongSolutions
Pat Distler, MS, MT(ASCP)SBB, ICCBBA
Adrian Gee, M.I.Biol, Ph.D., Center for Cell & Gene Therapy, Baylor College of Medicine

DESCRIPTION
This teleconference will review the status of ISBT 128 implementation in the fields of cellular therapy, tissue transplantation and derivatives worldwide. Discussion will include current and potential experience with using ISBT in these specialties. The presentation will be based on information available at the time of the audio conference. Speakers will discuss the advantages and obstacles involved with the implementation of ISBT 128 as well as how to select appropriate product codes. Tools that are available to simplify the selection of product codes will be demonstrated. Application of ISBT 128 to products drawn for the National Marrow Donor Registry will be presented. Efforts to integrate ISBT 128 from various patient service providers will be discussed. The use of ISBT 128 in electronic messaging between disparate computer systems and newer delivery mechanisms such as RFID will be also discussed.